A next-generation multitarget stool DNA test, including assessments of DNA molecular markers and hemoglobin level, was developed to improve the performance of colorectal cancer screening, primarily ...

Please provide your email address to receive an email when new articles are posted on . Approximately 48% of patients underwent a follow-up colonoscopy within 6 months of abnormal stool-based ...

Please provide your email address to receive an email when new articles are posted on . Compared with the original Cologuard test approved by the FDA in 2014, the company’s next-generation test uses ...

A stool test is a diagnostic procedure that involves analyzing fecal matter, or poop, to check for signs of infection, inflammation, or disease. The specific analysis depends on a person’s symptoms ...

Add Yahoo as a preferred source to see more of our stories on Google. A study conducted by UCLA researchers indicates sending unsolicited stool test kits to people aged 45-49 is the most effective way ...

Colorectal cancer is one of the leading causes of cancer deaths worldwide. Until now, colonoscopy has been the most reliable test, but many people avoid it because it is invasive, expensive, and ...

When given a choice, most individuals with an average risk of colorectal cancer said they would prefer a stool-based screening test for colorectal cancer over colonoscopy, the method most often ...

ST. LOUIS--(BUSINESS WIRE)--Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, today announced that the U.S. Food and Drug ...

Kentucky has one of the highest rates of colorectal cancer in the US, but early detection leads to a 91% five-year survival rate. Colorectal cancer is projected to become the leading cancer killer for ...

A calprotectin stool test is a noninvasive way to measure intestinal inflammation. It can help diagnose conditions like inflammatory bowel disease (IBD), gastrointestinal infections, and colorectal or ...